Skip to main content

Co-Diagnostics, Inc.

CODX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001692415

No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Co-Diagnostics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CODX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders4546+1
Shares4.44M4.49M+46.5K (+1.0%)
Value$4.93M$4.83M−$94.9K (−1.9%)

New holders (6)

Institutions that held Co-Diagnostics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CODX in Q3 2023
InstitutionSharesValue% of portfolio
Jane Street Group, LLC25,833$27.4K0.00%
Envestnet Asset Management Inc24,256$25.7K0.00%
XTX Topco Ltd21,763$23.1K0.00%
Two Sigma Securities, LLC16,626$17.6K0.00%
Group One Trading, L.P.144$1530.00%
Qube Research & Technologies Ltd13$140.00%

Sold out (5)

Institutions that held Co-Diagnostics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CODX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
First Trust Advisors LP81,176$90.1K
American Century Companies Inc11,393$12.6K
Federated Hermes, Inc.2,731$3.03K
First Horizon Advisors, Inc.1,400$1.55K
New Millennium Group LLC12$13